PAX6 and aniridia: The Pax6‐deficient (Pax6Sey+/−) mouse model of aniridia showed elevated Pax6 expression and reversed malformation defects in response to ataluren (PTC124) and geneticin (G418) treatment (Gregory‐Evans et al., 2014; Wang et al., 2017).